Q4 2024 Earnings Call Transcript November 18, 2024 Operator: Welcome to Twist Bioscience’s 2024 Fourth Quarter Financial ...

SOUTH SAN FRANCISCO, Calif. — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corp. (TWST) on Monday reported a loss of $34.7 million in its fiscal fourth quarter. On a per-share basis, the South San ...

Stilla Technologies, a global leader in digital PCR (dPCR) solutions, has announced a strategic partnership with Source ...

Daré Bioscience ( (DARE) ) has released its Q3 earnings. Here is a breakdown of the information Daré Bioscience presented to its investors.

Researchers at Ayass Bioscience have discovered and developed AYA22A aptamers, molecular compounds that target and bind to ...

Daré Bioscience, Inc. ( NASDAQ: DARE) Q3 2024 Earnings Conference Call November 14, 2024 4:30 PM ET MarDee Haring-Layton - CAO Sabrina Martucci Johnson - President and CEO ...

Bioscience and environmental science PhD students at UCL are to benefit from a share of a £500 million investment announced ...

Twist Bioscience (NASDAQ:TWST) is scheduled to announce Q4 earnings results on Monday, November 18th, before market open. The ...

University of Queensland researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that ...

Crown Partners arranged $30 million of senior financing from a U.S. commercial bank for HGS BioScience, a portfolio company ...

NWD will centre on four scientific and cross-cutting themes that bring together the complementary strengths of UoM and UoL in ...

SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, today reported financial results for the quarter ended ...